Infection

, Volume 42, Issue 4, pp 737–741

Echocardiographic screening for pulmonary arterial hypertension in HIV-positive patients

  • H. ten Freyhaus
  • D. Vogel
  • C. Lehmann
  • T. Kümmerle
  • C. Wyen
  • G. Fätkenheuer
  • S. Rosenkranz
Brief Report

Abstract

Human immunodeficiency virus (HIV) infection is associated with an increased risk for pulmonary arterial hypertension (PAH). Upon the screening of 220 asymptomatic HIV-positive individuals by echocardiography, we detected and confirmed HIV-associated PAH in 0.45 % of cases. Mild elevations of systolic pulmonary arterial pressure most probably owing to left ventricular diastolic dysfunction were found in 7.7 % of cases, without progress after 2 years. We suggest that the screening of asymptomatic HIV-positive patients for PAH should not be performed.

Keywords

HIV ART Pulmonary hypertension Left ventricular diastolic dysfunction Echocardiography 

References

  1. 1.
    Hoeper MM, Bogaard HJ, Condliffe R, Frantz R, Khanna D, Kurzyna M, et al. Definitions and diagnosis of pulmonary hypertension. J Am Coll Cardiol. 2013;62:D42–50. doi:10.1016/j.jacc.2013.10.032.PubMedCrossRefGoogle Scholar
  2. 2.
    D’Alonzo GE, Barst RJ, Ayres SM, Bergofsky EH, Brundage BH, Detre KM, et al. Survival in patients with primary pulmonary hypertension. Results from a national prospective registry. Ann Intern Med. 1991;115:343–9.PubMedCrossRefGoogle Scholar
  3. 3.
    Simonneau G, Gatzoulis MA, Adatia I, Celermajer D, Denton C, Ghofrani A, et al. Updated clinical classification of pulmonary hypertension. J Am Coll Cardiol. 2013;62:D34–41. doi:10.1016/j.jacc.2013.10.029.PubMedCrossRefGoogle Scholar
  4. 4.
    Mehta NJ, Khan IA, Mehta RN, Sepkowitz DA. HIV-related pulmonary hypertension: analytic review of 131 cases. Chest. 2000;118:1133–41.PubMedCrossRefGoogle Scholar
  5. 5.
    Rudski LG, Lai WW, Afilalo J, Hua L, Handschumacher MD, Chandrasekaran K, et al. Guidelines for the echocardiographic assessment of the right heart in adults: a report from the American Society of Echocardiography endorsed by the European Association of Echocardiography, a registered branch of the European Society of Cardiology, and the Canadian Society of Echocardiography. J Am Soc Echocardiogr. 2010;23:685–713; quiz 786–8. doi:10.1016/j.echo.2010.05.010.PubMedCrossRefGoogle Scholar
  6. 6.
    Sitbon O, Lascoux-Combe C, Delfraissy JF, Yeni PG, Raffi F, De Zuttere D, et al. Prevalence of HIV-related pulmonary arterial hypertension in the current antiretroviral therapy era. Am J Respir Crit Care Med. 2008;177:108–13. doi:10.1164/rccm.200704-541OC.PubMedCrossRefGoogle Scholar
  7. 7.
    Reinsch N, Neuhaus K, Esser S, Potthoff A, Hower M, Brockmeyer NH, et al. Prevalence of cardiac diastolic dysfunction in HIV-infected patients: results of the HIV-HEART study. HIV Clin Trials. 2010;11:156–62. doi:10.1310/hct1103-156.PubMedCrossRefGoogle Scholar
  8. 8.
    Schuster I, Thöni GJ, Edérhy S, Walther G, Nottin S, Vinet A, et al. Subclinical cardiac abnormalities in human immunodeficiency virus-infected men receiving antiretroviral therapy. Am J Cardiol. 2008;101:1213–7. doi:10.1016/j.amjcard.2007.11.073.PubMedCrossRefGoogle Scholar
  9. 9.
    Seaberg EC, Muñoz A, Lu M, Detels R, Margolick JB, Riddler SA, et al. Association between highly active antiretroviral therapy and hypertension in a large cohort of men followed from 1984 to 2003. AIDS. 2005;19:953–60. doi:10.1097/01.Aids.0000171410.76607.F8.PubMedCrossRefGoogle Scholar
  10. 10.
    Helleberg M, Kronborg G, Larsen CS, Pedersen G, Pedersen C, Gerstoft J, et al. Causes of death among Danish HIV patients compared with population controls in the period 1995–2008. Infection. 2012;40:627–34. doi:10.1007/s15010-012-0293-y.PubMedCrossRefGoogle Scholar
  11. 11.
    Ehren K, Hertenstein C, Kümmerle T, Vehreschild JJ, Fischer J, Gillor D, et al. Causes of death in HIV-infected patients from the Cologne–Bonn cohort. Infection. 2014;42:135–40. doi:10.1007/s15010-013-0535-7.PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2014

Authors and Affiliations

  • H. ten Freyhaus
    • 1
  • D. Vogel
    • 1
  • C. Lehmann
    • 2
  • T. Kümmerle
    • 2
  • C. Wyen
    • 2
  • G. Fätkenheuer
    • 2
    • 3
  • S. Rosenkranz
    • 1
  1. 1.Klinik III für Innere MedizinHerzzentrum der Universität zu KölnCologneGermany
  2. 2.Klinik I für Innere MedizinUniklinik KölnCologneGermany
  3. 3.German Centre for Infection Research (DZIF), partner site Bonn–CologneBraunschweigGermany

Personalised recommendations